DUBLIN, IRELAND--(Marketwire - Feb 26, 2013) - Elsevier Business Intelligence, publisher of "The Gray Sheet" and the medtech industry's leading provider of strategic partnership and investment conferences, will host the 'Investment-in-Innovation (IN3) Medical Device 360° Dublin' partnering and investment conference on April 16-18, 2013, at the The Shelbourne Dublin. This special event, which will bring together a diverse group of medtech's key thought leaders from among corporate business development execs, venture capital and angel investors, start-up entrepreneurs and industry pioneers, will feature a panel discussion:
Medtech Investing: How do VCs Assess their Potential Return-on-Investment? Despite the dire headlines, venture capitalists are still investing in medtech start-ups, even early stages. Learn what kind of deals the VCs are doing now and in the future and explore medical device investing, financing and exit strategies.
- Rationale behind the past few deals: How did they get on the radar?
- How are opportunistic and proactive ideas generated in certain clinical spaces?
- How does geography weigh-in on the decision to invest?
- What stage do certain VCs like to invest in and why?
- What is the solution for getting seed-stage investing?
- Talking to corporates early to map out your exit strategy.
Confirmed panelists will include: David Cassak (moderator), Vice President, Content, Elsevier Business Intelligence; Steve Levin (moderator), Editor-in-Chief, Elsevier Business Intelligence; Alan O'Connell, MSc, PhD, Partner, Seroba Kernel Lifesciences; John E. Milad, Investment Manager, NBGI Ventures; Antoine Papiernik, Managing Partner, Sofinnova Partners; Timothy Haines, Partner, Abingworth Management; Thom Rasche, Partner, Earlybird Venture Capital; Klaus Stoeckemann, Managing Partner, Peppermint Venture Partners GmbH.
In addition to all of the customary conference benefits, presenting company CEOs will have the opportunity to be interviewed on camera, at no charge, for a 3-minute exclusive video in which they may discuss their company and technology. These interviews will be featured post-conference at www.in3tv.com, to which a link will be provided to participating companies for their unrestricted use; availability of these video interviews will be broadly promulgated within the medtech industry. All one-on-one interviews with presenting-company CEOs will take place at, and during the IN3 Dublin conference and be organized by medtech PR/IR expert Ronald Trahan, President of Ronald Trahan Associates, Inc. Videotaping will take place on a scheduled basis only, on one day only of the event: Wednesday, April 17, from 13:00-17:30 local time. To schedule the free on-camera interviews contact firstname.lastname@example.org, or call +1-508-359-4005, x108.
An unprecedented number of additional top-tier international dealmakers are also confirmed to attend, including: Bard, Covidien, Edwards Lifesciences, Johnson & Johnson, Sorin, Stryker, Delta Partners, Fountain Healthcare Partners, Gilde, Imperial Innovations, Omnes Capital, Sofinnova, Wellington Partners, and many more. Further, IN3 Dublin will feature presentations by more than 30 early development- to commercial-stage start-up device companies seeking funding and/or strategic partnership. Confirmed presenters to date include: Access Bio, Aerogen, Aerolase, AltaScience, APICA Cardiovascular, Calon Cardio-Technology, Cardiograde, Chronix Biomedical, Clinical Laserthermia Systems, Expanding Orthopedics, FBC Device, Glysure, Humedics, i360medical, InControl Medical, Mainstay Medical, Mederi Therapeutics, MedLumics, Neuravi, Nordocs, Novate Medical, Quanta Fluid Solutions, SpineLab, Technopath, Vascular Flow Technologies, Veryan Medical, and WellBeingz.
Event co-sponsors include Ronald Trahan Associates Inc., Aptiv Solutions, Enterprise Ireland, Eucomed, Eugene F. Collins, IMDA, KPMG, Life Science Intelligence, Marketwire, MassMEDIC, Mass Medical Angels, Medmarc. Meditech, Seroba Kernel and Pharma Connections.
Visit www.in3dublin.com for full conference and registration details. Emerging medtech companies that would like to apply to present in Dublin should contact Kayleen Kell at 949-797-7142, or email email@example.com
About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.